{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:55:51Z","timestamp":1765806951468,"version":"3.38.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.taap.2011.01.013","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:24:00Z","timestamp":1296120240000},"page":"173-180","source":"Crossref","is-referenced-by-count":15,"title":["Secretory phospholipase A2-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2"],"prefix":"10.1016","volume":"251","author":[{"given":"Vishakha S.","family":"Bhave","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikiran","family":"Donthamsetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Latendresse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harihara M.","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2011.01.013_bb0005","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/2241320a0","article-title":"Effect of prostaglandin E2 on adjuvant arthritis","volume":"224","author":"Aspinall","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.taap.2011.01.013_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1677\/JOE-07-0234","article-title":"Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet","volume":"194","author":"Barbuio","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.taap.2011.01.013_bb0015","doi-asserted-by":"crossref","first-page":"29799","DOI":"10.1074\/jbc.M211763200","article-title":"Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation","volume":"278","author":"Beck","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2011.01.013_bb0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/hep.20590","article-title":"Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration","volume":"41","author":"Beraza","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2011.01.013_bb0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.taap.2007.12.025","article-title":"Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury","volume":"228","author":"Bhave","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.taap.2007.12.023","article-title":"Secretory phospholipase A2 mediates progression of acute liver injury in the absence of sufficient cyclooxygenase-2","volume":"228","author":"Bhave","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0035","series-title":"Side-Effects of Anti-Inflammatory Drugs 3","article-title":"Increased liver toxicity of diclofenac by paracetamol: results and possible mechanisms","author":"Brune","year":"1992"},{"key":"10.1016\/j.taap.2011.01.013_bb0040","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1096\/fj.01-0158fje","article-title":"Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy","volume":"15","author":"Casado","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2011.01.013_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1096\/fasebj.9.2.7781926","article-title":"Nutritional impact on the final outcome of liver injury inflicted by model hepatotoxicants: effect of glucose loading","volume":"9","author":"Chanda","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2011.01.013_bb0050","first-page":"477","article-title":"Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality","volume":"21","author":"Chanda","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2011.01.013_bb0055","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.2174\/138161205774370753","article-title":"Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer","volume":"11","author":"Claria","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.taap.2011.01.013_bb0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1358\/dnp.2000.13.10.661378","article-title":"Cyclooxygenase enzymes as targets for therapeutic intervention in inflammation","volume":"13","author":"Colville-Nash","year":"2000","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.taap.2011.01.013_bb0060","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1002\/eji.1830271254","article-title":"Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines","volume":"27","author":"Demeure","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2011.01.013_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.taap.2008.02.031","article-title":"Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPAR alpha with clofibrate","volume":"230","author":"Donthamsetty","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0168-8278(04)00086-8","article-title":"Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes","volume":"40","author":"Fernandez-Martinez","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2011.01.013_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(98)00508-1","article-title":"Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation","volume":"355","author":"Gilroy","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd1383","article-title":"Inflammatory resolution: new opportunities for drug discovery","volume":"3","author":"Gilroy","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2011.01.013_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1096\/fj.03-0837com","article-title":"A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation","volume":"18","author":"Gilroy","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2011.01.013_bb0090","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.107.128264","article-title":"Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor","volume":"323","author":"Horrillo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2011.01.013_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2741\/2045","article-title":"Animal models for the study of liver regeneration: role of nitric oxide and prostaglandins","volume":"12","author":"Hortelano","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.taap.2011.01.013_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1189\/jlb.0403152","article-title":"The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice","volume":"75","author":"Ishida","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2011.01.013_bb0105","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.4049\/jimmunol.151.8.4286","article-title":"Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2","volume":"151","author":"J\u00e4\u00e4ttel\u00e4","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2011.01.013_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)29664-1","article-title":"Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo","volume":"187","author":"Jollow","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2011.01.013_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FJC.0b013e3181ef1aab","article-title":"Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induced by isoproterenol infusion in mice after myocardial infarction","volume":"56","author":"Kawabata","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0120","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.placenta.2005.11.009","article-title":"15-Deoxy-Delta(12, 14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues","volume":"27","author":"Lappas","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.taap.2011.01.013_bb0125","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2011.01.013_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0041-008X(03)00250-3","article-title":"Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants","volume":"191","author":"Limaye","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.21250","article-title":"Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity","author":"Limaye","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2011.01.013_bb0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/shk.0b013e3180487ba1","article-title":"Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence","volume":"28","author":"Malleo","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.taap.2011.01.013_bb0145","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0006-2952(91)90249-5","article-title":"Role of hepatocellular regeneration and hepatolobular healing in the final outcome of liver injury. A two-stage model of toxicity","volume":"42","author":"Mehendale","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0150","series-title":"Drug-Induced Liver Disease","article-title":"Role of tissue repair in liver injury","author":"Mehendale","year":"2007"},{"key":"10.1016\/j.taap.2011.01.013_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2005.10.005","article-title":"Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?","volume":"79","author":"Menschikowski","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.taap.2011.01.013_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21034","article-title":"Deoxyribonuclease 1 aggravates acetaminophen-induced liver necrosis in male CD-1 mice","volume":"43","author":"Napirei","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2011.01.013_bb0165","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.4049\/jimmunol.152.12.5703","article-title":"Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2","volume":"152","author":"Oppenheimer-Marks","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2011.01.013_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.shk.0000223121.03523.69","article-title":"Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages","volume":"26","author":"Piraino","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.taap.2011.01.013_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0163-7258(93)90067-N","article-title":"Liver cytoprotection by prostaglandins","volume":"58","author":"Quiroga","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2011.01.013_bb0180","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/tx0155505","article-title":"A protective role for cyclooxygenase-2 in drug-induced liver injury in mice","volume":"14","author":"Reilly","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2011.01.013_bb0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/01902140903288026","article-title":"Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model","volume":"36","author":"Sato","year":"2010","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.taap.2011.01.013_bb0215","first-page":"53","article-title":"Fatty-acid substrate interactions with cyclo-oxygenases","volume":"31","author":"Smith","year":"2000","journal-title":"Ernst Schering Res. Found. Workshop."},{"key":"10.1016\/j.taap.2011.01.013_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/019262339101900106","article-title":"Role of hepatocellular regeneration in CCl4 autoprotection","volume":"19","author":"Thakore","year":"1991","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2011.01.013_bb0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/019262339402200307","article-title":"Effect of phenobarbital and mirex pretreatments on CCl4 autoprotection","volume":"22","author":"Thakore","year":"1994","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2011.01.013_bb0200","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1163\/156856005774382788","article-title":"Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats","volume":"12","author":"Whitehouse","year":"2005","journal-title":"Inflammopharmacol."},{"key":"10.1016\/j.taap.2011.01.013_bb0205","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0192-0561(00)00064-3","article-title":"Resolution of inflammation","volume":"22","author":"Willoughby","year":"2000","journal-title":"Int. J. Immunopharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:39:16Z","timestamp":1740893956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X11000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0041008X11000238"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2011.01.013","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}